Loss of Viral Fitness and Cross-recognition by CD8+ T Cells Limit HCV Escape from a Protective HLA-B27-restricted Human Immune Response
Overview
Authors
Affiliations
There is an association between expression of the MHC class I molecule HLA-B27 and protection following human infection with either HIV or HCV. In both cases, protection has been linked to HLA-B27 presentation of a single immunodominant viral peptide epitope to CD8+ T cells. If HIV mutates the HLA-B27-binding anchor of this epitope to escape the protective immune response, the result is a less-fit virus that requires additional compensatory clustered mutations. Here, we sought to determine whether the immunodominant HLA-B27-restricted HCV epitope was similarly constrained by analyzing the replication competence and immunogenicity of different escape mutants. Interestingly, in most HLA-B27-positive patients chronically infected with HCV, the escape mutations spared the HLA-B27-binding anchor. Instead, the escape mutations were clustered at other sites within the epitope and had only a modest impact on replication competence. Further analysis revealed that the cluster of mutations is required for efficient escape because a combination of mutations is needed to impair T cell recognition of the epitope. Artificially introduced mutations at the HLA-B27-binding anchors were found to be either completely cross-reactive or to lead to substantial loss of fitness. These results suggest that protection by HLA-B27 in HCV infection can be explained by the requirement to accumulate a cluster of mutations within the immunodominant epitope to escape T cell recognition.
Baig S, Berikkara A, Khalid R, Subhan S, Abbas T, Abidi S Front Microbiol. 2025; 15:1498069.
PMID: 39881992 PMC: 11774985. DOI: 10.3389/fmicb.2024.1498069.
Caragea A, Ursu R, Maruntelu I, Tizu M, Constantinescu A, Talangescu A Int J Mol Sci. 2024; 25(16).
PMID: 39201523 PMC: 11354460. DOI: 10.3390/ijms25168837.
SARS-CoV-2: pathogenesis, therapeutics, variants, and vaccines.
Li X, Mi Z, Liu Z, Rong P Front Microbiol. 2024; 15:1334152.
PMID: 38939189 PMC: 11208693. DOI: 10.3389/fmicb.2024.1334152.
Pisharodi M Cureus. 2024; 16(3):e55950.
PMID: 38469370 PMC: 10926937. DOI: 10.7759/cureus.55950.
Braun J, Rudwaleit M, Sieper J Z Rheumatol. 2023; 83(2):125-133.
PMID: 38112753 DOI: 10.1007/s00393-023-01460-0.